Kv1.3 Therapeutics' Unattributed Round

Kv1.3 Therapeutics raised a round of funding on December 13, 2017.

Kv1.3 Therapeutics is a biopharmaceutical focused on developing new treatment options for rare autoimmune diseases.…

Articles about Kv1.3 Therapeutics' Unattributed Round: